Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,921,003 papers from all fields of science
Search
Sign In
Create Free Account
LY 288513
Known as:
LY288513
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague–Dawley rats using elevated plus-maze test apparatus
J. Farook
,
Y. Zhu
,
Q. Wang
,
S. Moochhala
,
L. Lee
,
P. Wong
Neuroscience Letters
2004
Corpus ID: 23287967
1998
1998
Cholecystokinin B receptors in the periaqueductal gray potentiate defensive rage behavior elicited from the medial hypothalamus of the cat
B. Luo
,
Joseph W Cheu
,
A. Siegel
Brain Research
1998
Corpus ID: 25522123
Highly Cited
1997
Highly Cited
1997
Cholecystokinin and Psychiatric Disorders
J. Shlik
,
E. Vasar
,
J. Bradwejn
CNS Drugs
1997
Corpus ID: 45249451
SummaryCholecystokinin (CCK) is one of the most abundant neuropeptides in the brain. It is found in the highest levels in…
Expand
1997
1997
The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition
K. Rasmussen
,
M. Gates
,
James E Burger
,
J. F. Czachura
Neuroscience Letters
1997
Corpus ID: 38132600
1996
1996
Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
X. Ding
,
R. Håkanson
Acta Pharmacologica et Toxicologica
1996
Corpus ID: 19488222
The potency and specificity of five proposed cholecystokinin-B receptor antagonists, YM022, RP73870, L-740,093, L-365,260 and…
Expand
1996
1996
Central nervous system characterization of the new cholecystokininB antagonist LY288513
D. Helton
,
J. Berger
,
J. F. Czachura
,
K. Rasmussen
,
M. Kallman
Pharmacology, Biochemistry and Behavior
1996
Corpus ID: 25097725
1996
1996
The CCK‐B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle
K. Rasmussen
,
J. F. Czachura
,
M. Kallman
,
D. Helton
NeuroReport
1996
Corpus ID: 43860264
IN order to explore the potential clinical utility of CCK-B antagonists for the treatment of nicotine withdrawal symptoms, the…
Expand
1996
1996
Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats.
T. Izumi
,
T. Inoue
,
K. Tsuchiya
,
S. Hashimoto
,
T. Ohmori
,
T. Koyama
European Journal of Pharmacology
1996
Corpus ID: 4523491
Highly Cited
1993
Highly Cited
1993
Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
K. Rasmussen
,
J. F. Czachura
,
M. Stockton
,
J. Howbert
Journal of Pharmacology and Experimental…
1993
Corpus ID: 28440210
The diphenylpyrazolidinone cholecystokinin (CCK)-B antagonist LY262691 has recently been demonstrated to decrease the number of…
Expand
1993
1993
The CCK-B antagonist LY288513 blocks effects of diazepam withdrawal on auditory startle.
K. Rasmussen
,
D. Helton
,
J. Berger
,
E. Scearce
NeuroReport
1993
Corpus ID: 654329
In order to explore the potential clinical utility of CCK-B antagonists for the treatment of benzodiazepine withdrawal symptoms…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE